Monoclonal Antibodies: Stanford Academia-Industry Collaboration


     Related Videos

     More from this user
HIV and AIDS CURE :DR ROBERT (BOB) BECK EXTREMELY IMPORTANT!!!
DALLAS HAIR LOSS:NON-SCARRING ALOPECIA, ALOPECIA AREATA,ETC
Herpes Labialis treatment with ND:YAG laser
Hair restoration by BHT-FUE : Body Hair Transplant - Dr Umar
CONSPIRACY: 5 SOLUTIONS TO END SWINE FLU AH1N1
Herpes Treatment, Genital Herpes Treatment Option
Swine 9 Flu Symptoms
  • Swine 9 Flu Symptoms

  • Who started the swine flu virusSwne Flu Symptms Swin Flu Virus MexicoSwine Flu VaccineSwine Flu Pigs...

Medicaid Drug Therapy Management Program for Behavioral Health
Health from Mushrooms - Zdravlje iz gljiva (Croatian)

     Related Groups


 
  • Video url:                           Embed code: 

  • medical-video  status
    (0) (0 Votes)
    Views: (308)  
    Date:
    (13-09-09)  
    Time:
    (00:51:16)
  • Description: experiences moving his discovery from the lab to the clinical setting and discusses the future of this cancer treatment. Wendy Harpham, a participant in the early clinical trials of Rituxan, the first FDA-approved monoclonal antibody for cancer treatment that Levy developed, provides a patient's perspective. Stanford University School of Medicine: med.stanford.edu Stanford University Channel on YouTube: www.youtube.com ... medicine health disease therapy treatment research immune system ...

Write a Comment
     Related Documents




























 

Powered free by PHPmotion